Trade Summary

Yesterday, Titterton Lewis H jr, serving as Dir at Anixa Biosciences Inc (ANIX), purchased 12,000 shares at $3.47 per share, for a total transaction value of $41,640.00. Following this transaction, Titterton Lewis H jr now holds 986,967 shares of ANIX.

This purchase represents a 1.23% increase in Titterton Lewis H jr's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 20, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 20, 2026 at 6:19 PM ET, meaning the disclosure happened on the same day as the trade.

Anixa Biosciences Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.